Similarly, hypoxia, and in particular HIF-1α, drives the differentiation of myeloid-derived suppressor cells (MDSCs) into tumor-associated macrophages (TAMs), which guides cancer treatment. The gene discussed is HIF1A; the disease is neoplasm.